Similarly, promoter hypermethylation coupled with transcriptional silencing has been documented in loci coding for negative regulators of AKT, including tumor suppressor genes SCGB3A1 in NSCLC [192] and PPP2R2B in breast cancer [193], therefore contributing to cancer onset/progression. The gene discussed is AKT1; the disease is cancer.